Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand

PR55190

AMSTERDAM, Dec. 2 /PRN=KYODO JBN/ --

    CPhI announces that CPhI and P-MEC India, run by leading events organiser

UBM, is returning to the Bombay Convention and Exhibition Centre, Mumbai

(India) from the 3rd to the 5th December 2013. The event will return with an

increased scale, continuing its commitment to cater to all sectors of the

pharma industry by co-locating with ICSE and BioPh India.

    (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

    With a view to enhancing the customer experience and ROI value, CPhI India

has enhanced the mobile application, now available on all mobile devices with

an internet connection, designed to help attendees navigate their way around

the event, drive traffic to stands and stay up to date with schedules and

speaker events.

    With the addition of hall 7, P-MEC will host even more exhibitors than

previous years. Last year, there were 926 exhibitors present and this is

expected to rise to 1,000 this year to create the biggest show to date. Free

online registration to attend CPhI and P-MEC India is now closed, however

registration is still possible in Mumbai, the onsite fee is only INR500.

    India has increasingly become a focal point of the pharmaceutical industry

and is now the third largest in terms of volume. The country is fast becoming

an innovation hub, increasingly matching Western standards, whilst also

reducing the costs of manufacturing, showcasing the Indian pharma markets

unique position and providing an optimum investment platform for international

companies. Outside of the US, India has the highest number of FDA approved

facilities (546), and the Indian pharma sector received USFDA approvals for

around 40% of all Abbreviated New Drug Approvals (ANDA) during January-July

2013. Further, with R&D investments rapidly advancing, coupled with the rise in

generics and supergenerics, India represents a key maturing market, with CPhI

and P-MEC India facilitating opportunities to drive and enhance the sector.

    Ahead of the event, the UBM India pharma awards will take place on 2nd

December, celebrating the most innovative and dynamic areas across the Indian

pharma community. Honouring companies who are driving forward industry changing

initiatives, there will be awards for multiple categories including 'Excellence

in Product Development', 'Excellence in Contract Research' and 'Excellence in

Packaging Development'. The evening will also host a panel discussion on

'Moving up the Global Pharma Value Chain', designed to inform and educate those

present at the awards ceremony.

    "The global pharmaceutical market has seen a significant shift over the

last year, particularly as patent expirations are becoming more frequent and a

potential patent cliff is shaking the industry. India, however, is thriving as

the demand for generics is on the rise and companies are looking to drive down

manufacturing costs. India is well positioned to accommodate increased demand,

providing expertise in development and manufacturing. CPhI and P-MECIndia will

provide the ideal and essential platform for international and domestic

suppliers and buyers to break into the market." - Chris Kilbee, Group Director,

Pharma.

    Notes to editors

    About CPhI

    CPhI drives growth and innovation at every step of the global

pharmaceutical supply chain from drug discovery to finished dosage. Through

exhibitions, conferences and online communities, CPhI brings together more than

100,000 pharmaceutical professionals each year to network, identify business

opportunities and expand the global market. CPhI hosts events in Europe, China,

India, Japan, Southeast Asia, Russia and South America co-located with ICSE for

contract services, P-MEC for machinery, equipment & technology, InnoPack for

pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer

& supplier directory at CPhI-Online.com and hosts a global community with news

and analysis at PharmaEvolution.com.

    For more information visit: http://www.cphi.com

    The UBM Live annual schedule of Pharmaceutical events also includes CPhI,

ICSE, P-MEC, BioPh and Pharmatec Japan (9-11 April, 2014 in Tokyo); CPhI Russia

and IPhEB (16-17 April, 2014 in St Petersburg, Russia); CPhI, P-MEC and

Innopack South East Asia (20-22 May, 2014 in Jakarta, Indonesia); CPhI Istanbul

(4-6 June, 2014, Turkey) and CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld

China (26-28 June, 2014 at SNIEC, Shanghai, China), CPhI South America (5-7

August 2014 at Expo Centre Norte, Sao Paulo- Brazil); CPhI Worldwide, ICSE,

P-MEC Europe and InnoPack (7-9 October, 2013 at Nord Ville Pinte Paris, France)

    For media enquiries, please contact:

    Alex Heeley or Tristan Jervis

    De Facto Communications

    T: +44(0)207-203-6745

    E: a.heeley@defacto.com, t.jervis@defacto.com

    Source: UBM Live